SAB Biotherapeutics (SABS) Change in Account Payables (2021 - 2026)
SAB Biotherapeutics' Change in Account Payables was $674,881 in Q2 2026, up 389.7% from $137,829 a year earlier and up 491.4% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Change in Account Payables (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, SAB Biotherapeutics' Change in Account Payables was $1.45 million through Jun 30, 2026, down 6.3% year-over-year; for FY2025, it came in at $1.48 million, up 60.6% from FY2024.
- Change in Account Payables shows a five-year compound annual growth rate of -22.2% (FY2020 to FY2025).
- In earlier years, Change in Account Payables was $923,323 in FY2024, -$2.7 million in FY2023, -$779,425 in FY2022 and -$2.94 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Change in Account Payables since Q1 2025.
- Compared with a year earlier, Change in Account Payables was higher in three of the last five quarters, with growth averaging 118.4%.
- Per Business Quant data, SABS's Change in Account Payables in the three quarters before Q2 2026 was $114,119 (Q1 2026), $324,527 (Q4 2025) and $336,266 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | -70.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 18.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | SAB Biotherapeutics | 255.49 Mn | 255.49 Mn | - | 674,881.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 674,881.00 |
| Mar 31, 2026 | 114,119.00 |
| Dec 31, 2025 | 324,527.00 |
| Sep 30, 2025 | 336,266.00 |
| Jun 30, 2025 | 137,829.00 |
| Mar 31, 2025 | 684,171.00 |
| Dec 31, 2024 | 590,385.00 |
| Sep 30, 2024 | 134,618.00 |
| Jun 30, 2024 | -45,037.00 |
| Mar 31, 2024 | 243,357.00 |
| Dec 31, 2023 | -105,773.00 |
| Sep 30, 2023 | -320,676.00 |
| Jun 30, 2023 | -41,114.00 |
| Mar 31, 2023 | -2.23 Mn |
| Dec 31, 2022 | -1.81 Mn |
| Sep 30, 2022 | 540,693.00 |
| Jun 30, 2022 | -37,758.00 |
| Mar 31, 2022 | 522,816.00 |
| Dec 31, 2021 | 338,327.00 |
| Sep 30, 2021 | -1.40 Mn |
API Access
SAB Biotherapeutics Change in Account Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-account-payables", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();